QuantLogix ← MDT scorecard
📅 MDT Earnings Preview
Medtronic plc
Next report (est.)
02/11/2027
Countdown
152 days
EPS growth YoY
+39.0%
Revenue growth YoY
+9.3%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
09/03/2026 ±2.8% +1.0% over-priced
11/25/2025 ±3.2% +2.1% over-priced
08/26/2025 ±3.4% +0.1% over-priced
02/25/2025 ±3.7% +0.3% over-priced
11/26/2024 ±2.2% -0.1% over-priced
08/27/2024 ±2.5% -0.6% over-priced
02/27/2024 ±2.6% +0.2% over-priced
11/30/2023 ±1.3% +0.5% over-priced
Across these reports, options implied an average ±2.7% move vs an actual average of 0.6% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2027 $1.14 $9.8B $1.5B
Q4 FY2026 — $0 $0
Q2 FY2026 $1.07 $9.0B $1.4B
Q1 FY2026 $0.81 $8.6B $1.0B
Analyst posture
Buy / Strong Buy
23
Hold
11
Sell
0
Strong upward revisions — 33 net (vs 32 prior)
Live 5-factor engine read: Neutral · 50/100 Full scorecard →
Get alerted before every MDT report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on MDT before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Medtronic plc (MDT) reports in 152 days, with the next report estimated for 02/11/2027. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 0.6% on average — the market has systematically over-priced MDT's earnings risk. Fundamentals into the print: EPS up 39.0% year-over-year, revenue up 9.3%. QuantLogix's live 5-factor engine currently reads MDT as a neutral at 50/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →